A. Kotwani, K. Holloway
semanticscholar +1 more source
Correction: Clinical features of HAdV-55 in children with respiratory tract infections: a retrospective case series and literature review. [PDF]
Rao L+9 more
europepmc +1 more source
Sequence alignment of the SSU rRNA of the two Lophomonas species, L. blattarum and L. striata. The red rectangle highlights the position of the reverse universal primer; the yellow, the L. blattarum‐specific forward primer; and the green, the L. striata‐specific forward primer used in multiplex PCR.
Maryam Nakhaei+6 more
wiley +1 more source
<i>Moraxella catarrhalis</i> - An underestimated culprit for community-acquired lower respiratory tract infections in diseased adult lungs. [PDF]
Sengupta M+3 more
europepmc +1 more source
Pathogenicity and Bro gene typing of pediatric lower respiratory tract infections with Moraxella catarrhalis in Southwest Shandong, China. [PDF]
Xiang Y, Shi J, Han L, Yang C, Lu S.
europepmc +1 more source
Bocavirus in Children with Respiratory Tract Infections
Jianwei Wang+10 more
openaire +4 more sources
E. faecalis was the predominant species (60.7%). Moreover, 39.3% of the isolates were identified as VRE with an MIC > 32 μg/mL, and the vanA gene was detected in 35.7% of the isolates. High‐level resistance to gentamicin and streptomycin was observed in 60.7% and 50% of the isolates, respectively.
Maryam Koleini+3 more
wiley +1 more source
The influence of weather and urban environment characteristics on upper respiratory tract infections: a systematic review. [PDF]
Hyrkäs-Palmu H+3 more
europepmc +1 more source
Initially, 166 subjects aged 65 years or older with severe LRTIs met the diagnostic criteria, but 30 cases were excluded due to incomplete clinical data, and 17 cases were excluded due to the presence of malignancies, connective tissue diseases, or long‐term use of immunosuppressive agents. Ultimately, 119 patients were included in the study. The study
Tianqi Qi+8 more
wiley +1 more source
The selection of ventilation devices in children with mild or moderate upper respiratory tract infections: a randomised controlled trial. [PDF]
Shi J, Liu X, Chen W, Bao W.
europepmc +1 more source